GSK, Zofran Users Bicker Over Scope Of Patient Discovery
By Alison Noon · April 25, 2018, 7:56 PM EDT
Counsel for GlaxoSmithKline and families who claim its anti-nausea medication Zofran caused various birth defects argued in Boston federal court Wednesday over how many patients should be targeted for individual discovery in...
To view the full article, register now.